Evoke Pharma, Inc. (EVOK)
10.94
+0.01
(+0.09%)
USD |
NASDAQ |
Dec 10, 16:00
10.94
0.00 (0.00%)
After-Hours: 17:18
Evoke Pharma Profit Margin (Quarterly): -26.99% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tactile Systems Technology, Inc. | 9.57% |
| Sarepta Therapeutics, Inc. | -45.06% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -104.5% |
| Return on Assets | -32.76% |
| Return on Invested Capital | -51.69% |
| Gross Profit Margin (Quarterly) | 97.62% |
| Operating Margin (Quarterly) | -26.56% |
| Return on Net Operating Assets | -144.3% |